One in four doctors don’t tell myeloma patients about drugs not approved by NICE

BMJ 2008; 337 doi: (Published 27 August 2008) Cite this as: BMJ 2008;337:a1453
  1. Zosia Kmietowicz
  1. 1London

    A quarter of doctors caring for people with myeloma admitted that they did not tell their patients about licensed drugs that were not yet approved by the National Institute for Health and Clinical Excellence (NICE), to avoid distressing them, a survey shows.

    The telephone poll of 103 myeloma specialists in England, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial